Jason M Hataye

Title: Innovations by Jason M Hataye

Introduction

Jason M Hataye is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of protease inhibitors. His work focuses on creating novel compounds that have potential therapeutic applications.

Latest Patents

One of Jason's notable patents is titled "(Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors." This invention provides novel compounds of the Formula (I): A-B, its prodrug forms, or pharmaceutically acceptable salts thereof. In this formula, A represents a saturated, unsaturated, or partially unsaturated bicyclic heterocyclic ring structure, while B represents an aryl or a heteroaryl group. Preferred compounds include those with a benzimidazole or indole nucleus. These compounds are designed to inhibit serine proteases, Urokinase (uPA), Factor Xa (FXa), and/or Factor VIIa (FVIIa), making them valuable as anti-cancer agents and anticoagulants for treating or preventing thromboembolic disorders in mammals. Jason holds 1 patent for this innovative work.

Career Highlights

Jason M Hataye is currently employed at Axys Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His expertise in the pharmaceutical industry has positioned him as a key player in the innovation of therapeutic agents.

Collaborations

Some of Jason's coworkers include Darin A Allen and Witold N Hruzewicz, who contribute to the collaborative environment at Axys Pharmaceuticals, Inc. Their combined efforts enhance the research and development processes within the company.

Conclusion

Jason M Hataye is a notable inventor whose work in protease inhibitors has the potential to impact the pharmaceutical industry significantly. His innovative compounds and dedication to research exemplify the spirit of invention in modern medicine.